Related by context. All words. (Click for frequent words.) 77 Taiho Pharmaceutical Co. 75 TKPHF 75 Teijin Pharma Limited 75 Kissei Pharmaceutical 74 methylnaltrexone bromide 74 Nippon Shinyaku 74 Kissei Pharmaceuticals 73 Thrombin topical Recombinant 73 Daiichi Suntory Pharma 73 Handok Pharmaceuticals 73 Nippon Kayaku 73 RECOTHROM ® 72 Kyowa Hakko Kirin 72 JCR Pharmaceuticals 72 Kyowa Hakko Kogyo Co. 72 Tibotec BVBA 72 Galderma SA 72 JOULFERON 72 Taisho Pharmaceuticals 71 Sankyo Co. 71 Onalta TM 71 commercialize AzaSite 71 Kissei 71 commercialize telaprevir 71 JV SpeBio 71 AnGes MG 71 Hisamitsu Pharmaceutical Co. 71 Ube Industries Ltd. 71 Tanabe Seiyaku 71 Pharmion Corporation 70 Nihon Kohden Corporation 70 Gentamicin Surgical Implant 70 Santen Pharmaceutical 70 Kyowa Hakko Kogyo 70 Mitsubishi Tanabe Pharma 70 Teijin Pharma 70 Zenyaku Kogyo 70 Roche OTC RHHBY 70 Japanese drugmaker Daiichi 70 Seikagaku 70 ZALBIN 70 Pirespa 70 Campto 70 Seikagaku Corporation 70 commercializing Loramyc ® 70 MOVIPREP R 70 Fujisawa Healthcare Inc. 70 Kaketsuken 70 Otsuka Pharmaceuticals 70 Receives Orphan Drug Designation 69 Napo Pharmaceuticals 69 Rohto Pharmaceutical 69 Meiji Seika Kaisha Ltd. 69 label Lipofen R 69 Aloxi ® 69 RELISTOR ® 69 Teikoku Pharma USA 69 Initiates Enrollment 69 Gendux AB 69 Fresenius Biotech 69 Roche SWX ROG 69 oncolytic virus therapies 69 SpeBio joint venture 69 Fortigel 69 AnGes 69 Takeda Pharma 69 NASDAQ SCMP 69 Potelligent Technology 69 Dainippon Pharmaceutical 69 Glufast 69 compound KOS 69 Teikoku Seiyaku Co. 69 Therapeutic Competitors Report 69 Handok 69 Nycomed GmbH 69 Ono Pharmaceutical 69 Initiates Clinical Trial 69 Neulasta R 69 Loramyc 68 Oncolys BioPharma 68 Astellas Deutschland GmbH 68 Tostrex 68 HELSINN 68 TRANSDUR ™ 68 STRIANT ® 68 Albugon 68 Kissei Pharmaceutical Co. 68 Kyowa Kirin 68 apaziquone 68 Wafer polifeprosan 68 LUCASSIN 68 BioSante Pharmaceuticals Announces 68 Chugai Pharma 68 Receives Tentative Approval 68 XIAFLEX ® 68 Santen Pharmaceutical Co. 68 Intravenous Human 68 Rectogesic 68 INTERNATIONAL HOLDINGS INC. 68 Nabi HB R 68 Teikoku Seiyaku 68 Onalta 68 Oxford Genome Sciences 68 BUPHENYL R 68 TRANSDUR ® 68 Auxilium Pharma 68 TRACON Pharmaceuticals 68 NASDAQ PHRM 68 Meiji Seika 68 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 68 Nasdaq HALO 68 ospemifene 68 Fludara ® 68 Therapeutic Competitors Companies 68 Friedreich Ataxia FRDA 68 Oxis International 68 COLAZAL R 68 Portola Pharmaceuticals 68 cinacalcet HCl 68 STRIANT R 68 Tanabe Seiyaku Co. 68 Loramyc ™ 68 Cetrorelix 67 Cx# [002] 67 R bendamustine hydrochloride 67 Alfa Wassermann SpA 67 Receives Milestone Payment 67 RECOTHROM R 67 Alnylam Pharma 67 Eraxis 67 Kuvan R 67 Elan Pharma 67 Kyorin Pharmaceutical Co. 67 Initiates Phase II 67 Debiopharm SA 67 ChemGenex Pharmaceuticals Limited 67 NASDAQ ISIS 67 Targeted Chemotherapy 67 CIMYM 67 TAKEDA 67 Taisho Pharmaceutical Co. 67 Preotact 67 VISICOL R 67 Oracea ® 67 BUPHENYL 67 Nitazoxanide 67 DepoDur 67 Initiates Phase III 67 Nippon Shinyaku Co. 67 Azur Pharma 67 aerosolized AAT 67 Nasdaq SPPI 67 Files IND 67 AnGes MG Inc. 67 Immtech Pharmaceuticals Inc. 67 Oncoscience AG 67 Myrexis Inc. 67 Nutra Pharma wholly owned 67 Kyorin Pharmaceutical 67 IV Busulfex 67 testosterone buccal system 67 R sorafenib tablets 67 Dynepo TM 67 Advancis Pharmaceutical Corporation 67 MediBIC 67 OTCBB HNAB 67 HuMax TAC 67 Sensipar R 67 commercialize Hematide 67 Taisho Pharmaceutical 67 ZADAXIN ® 67 Completes Patient Enrollment 67 SYCREST 67 ZARS Pharma 67 ASX PGL 67 highly purified pasteurized 67 Initiates Clinical 67 equine osteoarthritis marketed 67 FOLOTYN ® 67 Asahi Kasei Pharma 67 BioGlue ® 67 Metabasis Therapeutics 67 Idec Roche Takeda 67 CoTherix 67 Oncolys 67 Gedeon Richter Plc 67 FUSILEV ® 67 IG HCR ;) CO 67 Nasdaq CRXL 67 Vernalis plc 67 UMN Pharma 67 Modrenal R 67 Esmya 67 P#X# antagonist 67 Therapeutic Competitors companiesandmarkets.com adEgemonye 67 Alfa Wassermann 67 Ridaforolimus 67 candidates Azedra TM 67 Sanvar 67 Canadian drugmaker Aeterna 67 OncoTherapy Science 67 Announce License Agreement 67 Raptiva R 67 LymphoStat B TM 66 copromotion 66 Orapred ODT 66 Amira Pharmaceuticals 66 Tibotec Pharmaceuticals Ltd. 66 Xcytrin R 66 commercialize OncoGenex lead 66 acne impetigo 66 Idera Pharmaceuticals 66 hepatitis B HBV 66 NASDAQ PGNX 66 Pegloticase 66 Agenerase 66 Psivida 66 CytoPharm 66 CIMZIA r 66 Campath ® 66 DOV Pharmaceutical 66 EHT AGN 66 commercialize Aganocides 66 markets HP Acthar 66 Loramyc R 66 Shin Poong 66 VYVANSE TM lisdexamfetamine 66 Alnara Pharmaceuticals 66 Inc. OTCBB ALRX 66 Indaflex 66 Nexavar ® 66 Civacir 66 Merck Sante sas 66 NV Organon 66 Sebivo 66 candidates Azedra 66 Solasia 66 Commercialization Agreement 66 InvaGen 66 ELADUR ™ 66 PHX# 66 Proquin XR 66 Luveris R Ovidrel R 66 Helsinn Healthcare SA 66 FDA APPROVES 66 ELADUR TM 66 Copegus R 66 Alnylam Nasdaq ALNY 66 YONDELIS R 66 SUPPRELIN R LA 66 DAIICHI SANKYO 66 Cellegesic 66 Antisense Pharma GmbH 66 Dacetuzumab 66 Merck Serono division 66 Receives Approvable Letter 66 XAGRID 66 PGL# 66 Clevudine 66 Soliris eculizumab 66 Biomarin 66 NASDAQ DRRX 66 outlicensed 66 Chipscreen 66 NASDAQ CRXL 66 Ceflatonin R 66 Insegia 66 successfully commercialize Iluvien 66 commercialize becocalcidiol patented 66 EMD Biosciences Inc. 66 Evoltra ® 66 Initiates Clinical Trials 66 Daclizumab 66 acyclovir Lauriad R 66 Norgine BV 66 Receives Orphan Drug 66 Ascenta Therapeutics 66 Mycamine 66 Asentar TM 66 commercialize Aganocide compounds 66 Announces Tentative Approval 66 OTCBB PYTO 66 Zenpep 66 RELOVAIR ™ 66 Hextend R 66 Kosan motilin agonist 66 Submits Biologics License Application 66 Locteron exclusively 66 Sankyo Pharma 66 Oscient Pharmaceuticals 66 Nabi HB ® 66 Kristalose ® lactulose 66 Submits NDA 66 Fortical R 66 Granted Orphan Drug 66 Epiphany Biosciences 66 Vitrasert R 66 RHEI Pharmaceuticals 66 PentaLyte R 66 Prometheus Laboratories 66 OTCBB HXBM developer 65 Oasmia 65 Sinobiomed Inc. 65 Prism Pharmaceuticals 65 AzaSite Xtra 65 HuMax HepC TM 65 Begins Dosing 65 NeutroPhase TM 65 Zegerid OTC 65 Aestus Therapeutics 65 Exploit collaboration 65 Liprotamase 65 ESTRASORB ® 65 Regeneron Pharma 65 Preotact R 65 VIVITROL ® 65 POTELLIGENT R Technology 65 Fortical ® 65 Xian Janssen 65 Xeloda ® 65 TM Aganocide 65 telomerase therapeutic 65 Tarsa Therapeutics 65 Alvesco ® 65 terlipressin 65 NasdaqGM SPPI 65 Presidio Pharmaceuticals 65 Iluvien ® 65 DosePro TM 65 bendamustine HCl 65 TaiGen 65 Syntonix Pharmaceuticals 65 Salmedix 65 vapreotide acetate 65 Cypress Bioscience Inc 65 dihydrochloride Tablets 65 please visit http:/www.vandapharma.com 65 Organon Pharmaceuticals 65 Vivecon 65 Vantas 65 Nasdaq IMGN 65 Tamibarotene 65 Pariet 65 QUADRAMET R 65 Nipent R 65 SinuNase ™ 65 liver resection surgeries 65 Vertex retains 65 Ortho Cept 65 Nasdaq PGNX today 65 LUNESTA ® 65 Adamis Pharmaceuticals 65 diarrhea predominant irritable 65 Cellgate Inc. 65 AMEX RGN 65 Receive Milestone Payment 65 Therapeutic Competitors 65 Urocidin TM 65 Asubio Pharma 65 Milestone Payments 65 Samjin 65 MEDAREX 65 oral salmon calcitonin 65 NUEDEXTA ™ 65 Naglazyme R galsulfase 65 Senju Pharmaceutical Co. 65 BioGlue R 65 Torii Pharmaceutical 65 Collategene 65 Kepivance 65 reslizumab 65 Visual Voicemail patent 65 Nasdaq CLDX 65 Quark Biotech 65 Personalized Immunotherapy 65 Kuvan TM sapropterin 65 Nasdaq AVNC 65 Suzuken 65 Crofelemer budesonide foam 65 BARACLUDE R 65 Nabi HB Intravenous 65 molecular imaging radiopharmaceutical 65 Mylan Receives Approval 65 AB OMXS BINV 65 Frova ® 65 Ikaria Holdings Inc. 65 mitiglinide 65 Kosan dependence 65 Merrimack Pharmaceuticals 65 Zemiva TM 65 mGluR4 PAM 65 anti CD3 monoclonal 65 synthetic retinoid 65 mesylate 65 ThermoDox R 65 Agonist MABA program 65 Argatroban 65 Aldara ® 65 Tezampanel 65 Esprit Pharma 65 OTCBB NPHC 65 Otsuka Pharmaceutical 65 commercialize elagolix 65 Immunotherapeutic 65 AMEX ISV 65 Helsinn Healthcare 65 Febuxostat 65 Synvisc ONE 65 sapropterin dihydrochloride 65 PRN FDA Approves 65 BF Biotech 65 Daewoong 65 lead molecular radiotherapeutic 65 Roche SIX RO 65 Primus Pharmaceuticals 65 Loramyc TM 65 Amitiza lubiprostone 65 KAI Pharmaceuticals 65 acetonide FA 65 Bayer Yakuhin 65 Apaziquone 65 IMiDs ® compound 65 Silodosin 65 oral dual endothelin 65 Zeneus 65 rasagiline tablets 65 ONCASPAR 65 TSX CTI 65 CDP# 65 Durect 65 SANOFI AVENTIS 65 Vaccinex 65 Nasdaq PHRM 65 ZALBIN ™ 65 bendamustine hydrochloride 65 candidate epratuzumab 65 IV APAP 65 Barrier Therapeutics Inc. 65 Adventrx Pharmaceuticals 65 Specialised Therapeutics 65 Epitomics 65 Penwest Pharmaceuticals Co 65 Femring ® 65 Azmacort R 65 ASX ANX 65 TYZEKA 65 Rapinyl 65 Laboratoires Thea 65 GenWay Biotech 65 ARCALYST R 65 Oracea TM 65 Nexavar sorafenib tablets 65 Inc Therapeutic Competitors 65 NASDAQ FLML 65 HepeX B 65 Hsp# Inhibitor 65 Lupin Pharmaceuticals 65 Aphton Corporation 65 SBL Vaccines 65 Nasdaq XTLB 65 cyclobenzaprine hydrochloride extended 65 recombinant thrombin 65 AVAX Technologies Inc. 65 REBETOL combination therapy 65 NASDAQ WCRX 65 candidate AQ4N 64 VivaGel ™ 64 Bendamustine 64 tafluprost 64 SymBio 64 BioDelivery Sciences Announces 64 carbonate Direct FuelCell 64 Chugai Pharma USA 64 commercialize dutogliptin 64 Lovaza TM 64 NASDAQ AEZS 64 Enhanze 64 Selective Electrochemical Tumor Ablation 64 Vifor Pharma 64 Mimpara R 64 MuGard TM 64 NeutroSpec TM 64 Idun Pharmaceuticals 64 BioNumerik 64 DRRX 64 miconazole MBT 64 CoTherix Inc. 64 PER.C6 r 64 Lexiscan ® 64 prostone 64 NPS NPS Pharmaceuticals 64 Nasdaq PGNX 64 Zentaris 64 Receives Fast Track 64 REGiMMUNE 64 Alinia 64 Nasdaq IDIX 64 GVAX ® 64 Toyama Chemical 64 Nanobody R 64 Bukwang Pharmaceuticals 64 Inc. AMEX YMI 64 Announces License Agreement 64 Takara Bio Inc. 64 t2cure GmbH 64 Copegus ® 64 Medicis Pharmaceutical Corp 64 Ciclesonide 64 mitogen activated ERK kinase 64 POTELLIGENT R 64 NitroMist TM 64 Soriatane R 64 memantine HCl 64 Xyntha 64 Pierre Fabre Medicament 64 Nuron Biotech 64 Vitamin D analogue 64 Cetrotide R 64 Bacterin develops manufactures 64 human C1 inhibitor 64 OMNARIS Nasal Spray 64 lexidronam injection 64 non nucleoside inhibitor 64 ALPMF 64 Alexion Pharma 64 Neovastat 64 Zorbtive TM 64 Aegera Therapeutics Inc. 64 Uvidem 64 Rotarix R 64 OTC RHHBY 64 Ganciclovir 64 Increlex TM 64 CIMAB SA 64 OTCBB NVDL 64 Locked Nucleic Acid 64 Kyowa Pharmaceutical Industry 64 GTC recombinant form 64 GlaxoSmithKline plc GSK 64 sanofi aventis EURONEXT SAN 64 BioOne Corporation 64 By JAMAAL ABDUL 64 GeneraMedix 64 AzaSite TM 64 Daiichi Pharmaceutical 64 fipamezole 64 proprietary radiolabeled monoclonal 64 Announces Poster Presentations 64 adenosine injection 64 HYVISC ® treatment 64 XTL Biopharmaceuticals Ltd. 64 DepoCyt 64 sorafenib tablets 64 Akorn Inc 64 Sustiva efavirenz 64 Hexvix ® 64 Cabrellis 64 SHP.L 64 Peginterferon alfa 2b 64 Japanese Encephalitis Vaccine 64 Successfully Completes Phase 64 NasdaqGM NTEC today 64 BXT # 64 candidate custirsen 64 Meda AB 64 FivePrime Therapeutics 64 Pafuramidine 64 SUMAVEL 64 NASDAQ NABI 64 License Option Agreement 64 XOPENEX R 64 Debiopharm Group 64 Twinject ® 64 Tyzeka Sebivo 64 Nasdaq ICOS 64 Submits Response 64 faropenem 64 Pandel R 64 OMRIX Biopharmaceuticals Inc. 64 NYSE Amex PTN 64 NASDAQ ONXX 64 Omigard TM 64 Seiyaku 64 Nasdaq ACHN 64 Trastuzumab DM1 64 angioedema indications 64 Nasdaq ALNY 64 #mg Tablets [002] 64 NovaDel Pharma 64 Genentech Wyeth Pharmaceuticals 64 Nitec Pharma 64 BRILINTA 64 Gonal f 64 TELINTRA 64 LHRH antagonist 64 Receives Marketing Authorization 64 novel emulsion formulation 64 Fujisawa Pharmaceutical Co. 64 glucokinase activator 64 Ixempra 64 REGPARA 64 NOVN 64 Nasdaq DVAX 64 ASE SVA 64 phase III isavuconazole 64 Bazedoxifene 64 Æterna Zentaris 64 ATG Fresenius S 64 Crucell NV Euronext 64 Astex Therapeutics 64 Diatos SA 64 StaphVAX R 64 Archemix Corp. 64 Bayer Yakuhin Ltd. 64 ImQuest Pharmaceuticals 64 Lubiprostone 64 PRNewswire FirstCall Sosei 64 Valortim TM 64 INOmax 64 HIV integrase inhibitor 64 PAION AG ISIN 64 NASDAQ MOGN 64 Dexilant 64 include Altastaph TM 64 BCR ABL inhibitors 64 F. Hoffmann LaRoche 64 Adagen ® 64 TolerRx 64 Nasdaq VRTX today 64 Chemo Sero Therapeutic 64 Merck Serono SA 64 Myocet 64 STO SOBI 64 Onco TCS 64 Durect Corporation 64 selective immunoproteasome inhibitor 64 sapropterin dihydrochloride Tablets 64 CysDisplay R 64 Alcortin R 64 Tech Ueno 64 intravenous AAT 64 Essex Chemis AG 64 NASDAQ CLSN 64 Yakult Honsha 64 Aflibercept 64 PEGylated anti 64 CyDex Pharmaceuticals 64 UCB Cimzia R 64 SOLVAY PHARMACEUTICALS 64 HepaGam B R 64 quinolone antibiotic 64 Ecallantide 64 developing Zerenex ferric 64 commercialize XP# 64 Septin9 biomarker 64 mGluR2 positive 64 NYSE Amex PBTH 64 Cardium Therapeutics TM 64 NASDAQ ALNY 64 Gonal f R 64 Files Investigational 64 Drug Candidate 64 Busulfex 64 ® tiagabine hydrochloride 64 tivozanib AV 64 subsidiaries InnerCool Therapies 64 mertansine 64 Qutenza TM 64 vancomycin hydrochloride 64 AMITIZA ® 64 Receives CE Marking 64 Cellegy Pharmaceuticals 64 Drug Eluting Stent System 64 Levoleucovorin 64 GILD GILD 64 OTCBB IMNR 64 valtorcitabine 64 Nasdaq OPTR 64 tiapamil 64 YONDELIS 64 Initiates Dosing 64 Mitsubishi Pharma 64 Acuity Pharmaceuticals 64 MERREM 64 sumatriptan succinate 64 Arno Therapeutics 64 laninamivir 64 ABILIFY R 64 Inc. Nasdaq IDMI 63 Mersana Therapeutics Inc. 63 BioSpecifics Technologies Corp. 63 NASDAQ OSIP announced 63 Alnylam Pharmaceuticals Nasdaq ALNY 63 novel antibody therapeutics 63 Ethypharm SA 63 Pancreas Cancer Vaccine 63 arsenic trioxide injection 63 Novartis VIRT X 63 MKC# MKC# PP 63 OMRIX Biopharmaceuticals 63 OncoGenex Technologies 63 ABILIFY ® 63 TSX PLB 63 SPRYCEL ® 63 Catalyst Biosciences 63 Vidaza R 63 LEVADEX TM 63 CAPHOSOL R 63 Crucell NV NYSE Euronext 63 MEZAVANT 63 OTCBB ADXS 63 Teplizumab 63 targeted radiotherapeutic 63 ATL# [002] 63 Meets Primary Endpoint 63 PF # [002] 63 Enters Into Collaboration 63 Exelixis logo 63 Nasdaq NPSP 63 NEUPOGEN R 63 Atripla combines 63 Banyu Pharmaceutical Co. 63 PregLem 63 vinorelbine tartrate 63 developing Bicifadine serotonin 63 anti CD# monoclonal 63 Nasdaq ANPI 63 Ethyol 63 Milestone Payment 63 Somatuline Depot 63 SIX RO ROG 63 Yakult Honsha Co. 63 Melior Discovery 63 TSX SHQ 63 NASDAQ DIGE 63 cosmetic cosmeceutical products 63 Psoriasis Drug 63 Tibotec Therapeutics division 63 Sigma Tau Pharmaceuticals 63 Ondansetron Injection 63 GlaxoSmithKline Biologicals SA 63 BYETTA ® 63 Miravant Medical Technologies 63 HuCAL GOLD R 63 subsidiary Glenmark Generics 63 NASDAQ PPDI 63 Enzon Pharmaceuticals Inc 63 CEDAX ® 63 Anadis Limited 63 PentaStaph 63 Astellas Pharma Inc 63 JAK2 Inhibitor 63 Nasdaq OSIP 63 Presents Positive Preclinical 63 Initiate Clinical Trial 63 Chugai Pharmaceutical Co 63 Sanwa Kagaku Kenkyusho 63 AEterna Zentaris Inc. 63 DOV Pharmaceutical Inc. 63 Janssen Pharmaceutica NV 63 NASDAQ LGND 63 Isis Pharma 63 commercialize Dimebon 63 GeneraMedix Inc. 63 Viventia Biotech Inc. 63 Grunenthal GmbH 63 investigational pharmacologically unique 63 Mochida Pharmaceutical Co. 63 Frova R 63 DAIICHI SANKYO COMPANY LIMITED 63 Lilly ICOS LLC 63 ALN HPN 63 Periostat R 63 ALZA Corporation 63 Kuhnil 63 Ceragenix 63 THALOMID 63 Quark Biotech Inc. 63 Bertek Pharmaceuticals 63 Nasdaq ONXX 63 Raptiva ® 63 Namenda Memantine HCl 63 CD# CEA 63 ZEVALIN ® 63 Wellstat 63 topical NSAID 63 OTCBB INSV 63 AsiaPharm Group 63 GATTEX TM 63 Carna Biosciences 63 Aloxi R 63 include Healive 63 Recombinant Human 63 rxRNA 63 EnzymeRx 63 Solazed TM 63 Æterna Zentaris Inc. 63 developing TB4 63 Nasdaq HALO biopharmaceutical 63 zileuton tablets 63 TSX AEZ 63 pralatrexate injection folate analogue 63 TRAIL receptor antibodies 63 Cosmo Pharmaceuticals 63 drug ISA# 63 Creabilis Therapeutics 63 dermatology therapies 63 Stanate R 63 Zor Pharmaceuticals 63 Orphan Drug designations 63 Nereus Pharmaceuticals 63 Cutanea Life Sciences 63 pentadentate logo R 63 MEK Inhibitor 63 deCODE chemistry 63 RAPTIVA r 63 Alligator Bioscience AB 63 RhuDex ® 63 registrational studies 63 ALIM 63 DELATESTRYL R 63 Veronate R 63 Investigational Treatment 63 Lexiscan R 63 Fovea Pharmaceuticals 63 Elagolix 63 small molecule thrombopoietin 63 refractory chronic lymphocytic 63 ACTIQ ® 63 Astellas Pharmaceuticals 63 Meritage Pharma 63 NASDAQ OGXI 63 Affitech AS 63 Humira adalimumab 63 Aganocide ® 63 Oral Suspension USP 63 NewBridge Pharmaceuticals 63 Metaphore Pharmaceuticals 63 GTC NASDAQ GTCB 63 ParinGenix 63 Inspire Pharma 63 proteasome inhibitor 63 Eligard ® 63 Paladin Labs 63 Axcan Pharma Holding BV 63 Crop BioScience 63 Glenmark Generics Limited 63 Ercole Biotech 63 Somaxon Pharmaceuticals 63 Zensana TM 63 Akela Pharma Inc. 63 Completes Dosing 63 OTCBB IMUC 63 EKR Therapeutics 63 Isis Pharmaceuticals Inc 63 Nippon Kayaku Co. 63 MKC# MT 63 induced macular edema 63 Prochymal TM 63 Actemra tocilizumab 63 Calixa Therapeutics 63 Finacea 63 Allovectin 7 63 Sankyo Pharma Inc. 63 Astellas Pharma #.T 63 Genelabs Technologies 63 candidate XP# 63 BioMarin Genzyme LLC 63 Deferiprone 63 Portola Pharmaceuticals Inc. 63 Propofol IDD D 63 NASDAQ BJGP 63 Advancing Drugs 63 Pharma Merck Serono 63 Generex Biotechnology 63 Biovitrum AB 63 Nasdaq CADX 63 Licenses Novel 63 StromaCel Inc. 63 BioWa 63 Argenta Discovery 63 GlaxoSmithKline MedImmune 63 Benicar HCT 63 ZYFLO R 63 TRISENOX ® 63 Allos retains exclusive 63 InterfeRx 63 Ucyclyd Pharma Inc. 63 Tibotec Pharmaceuticals 63 Mycograb 63 UltiMAb 63 overactive bladder VANTAS R 63 docosanol 63 IgG1 monoclonal antibody 63 TTY Biopharm 63 Excellarate TM 63 ALVESCO ® 63 Metabasis Therapeutics Inc. 63 Obtains License 63 Dainippon Sumitomo 63 Cordex Pharma 63 Kaneka Corporation 63 5 HT3 antagonist 63 sublicensee 63 Cytokine PharmaSciences 63 Kosan Biosciences Incorporated 63 Commence Phase 63 Sign Licensing Agreement 63 Staphylococcus aureus Immune Globulin 63 Dainippon Sumitomo Pharma 63 Astellas Pharma Inc. 63 Ganite ® 63 POSIDUR TM ELADUR TM 63 Nexavar sorafenib 63 NSE SUNPHARMA 63 BTRX 63 Cetuximab Erbitux 63 Transdermal Patch 63 Kureha Corporation 63 AMEX REX 63 IDEV Technologies 63 trastuzumab Herceptin R 63 thymosin alpha 1 63 Aviptadil 63 ESpy TM 63 personalized cellular immunotherapy 63 Irinotecan 63 Nasdaq CGEN 63 Cleviprex TM clevidipine 63 recombinant biopharmaceutical 63 Phusion Laboratories 63 Nasdaq OMER 63 ergot derivatives 63 IL# PE#QQR 63 XL# anticancer compounds 63 ACADIA Pharmaceuticals 63 ProEthic Pharmaceuticals 63 BTG plc 63 Zenyaku Kogyo Co. 63 FOR FURTHER INFORMATION ABOUT 63 Entecavir 63 STRIANT 63 NGSX 63 Nasdaq CYTR biopharmaceutical 63 candidate Zenvia 63 Remicade infliximab 63 Enters Into Licensing Agreement 63 Faropenem 63 Restoraderm R 63 NASDAQ CRTX 63 Syndrome LEMS 63 Aphios Corporation 63 commercialize peramivir 63 HYVISC R 63 Eloxatin ® 63 Ipsen SA 63 FACTIVE R gemifloxacin 63 Nektar Therapeutics NKTR 63 Berinert 63 Eligard R 63 lexidronam injection PROSTASCINT 63 Vernalis Plc 63 AION Diagnostics 63 Allovectin 7 r 63 Nasdaq AVNR 63 Gleevec imatinib mesylate 63 NASDAQ RNAI 63 PharmaVitae Profile 63 Optimer Pharmaceuticals Inc 63 Barrier Repair 63 BioTie 63 R#/MEM 63 Combination REOLYSIN R 63 Nasdaq MICU 63 technology NeoVisc 63 anti infective treatments 63 Afferent Pharmaceuticals 63 NASDAQ PCYC 63 Sanvar R 63 STELARA TM 63 hyperimmune products 63 OPi 63 OSI Oncology 63 Aradigm Logo 63 subsidiaries visit http:/www.apricusbio.com 63 Lexapro escitalopram 63 PROLOR Biotech Inc. 63 AstraZeneca MedImmune 63 Bayhill Therapeutics 62 SansRosa 62 Submits Supplemental 62 Regulus Therapeutics 62 Surgical Adhesive 62 EMD Merck 62 Indaflex TM 62 Oxford BioTherapeutics 62 ENZON 62 Fumapharm AG 62 MorphoSys AG FSE MOR